{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Env epitopes and drug resistance mutations", "intra-patient viral diversity", "near full genome sequencing", "third-generation sequencing", "unique recombinant forms"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31353798", "DateCompleted": {"Year": "2020", "Month": "04", "Day": "27"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["e25362", "10.1002/jia2.25362"], "Journal": {"ISSN": "1758-2652", "JournalIssue": {"Volume": "22", "Issue": "7", "PubDate": {"Year": "2019", "Month": "Jul"}}, "Title": "Journal of the International AIDS Society", "ISOAbbreviation": "J Int AIDS Soc"}, "ArticleTitle": "Near full genome characterization of HIV-1 unique recombinant forms in Cameroon reveals dominant CRF02_AG and F2 recombination patterns.", "Pagination": {"StartPage": "e25362", "MedlinePgn": "e25362"}, "Abstract": {"AbstractText": ["In Cameroon, a manifold diversity of HIV strains exists with CRF02_AG and unique recombinant forms (URFs) being the predominant strains. In recent years, a steady increase in URFs and clade F2 viruses has been monitored through partial genome sequencing. There is an information gap in the characterization of emerging URFs along the full genome, which is needed to address the challenges URFs pose towards diagnosis, treatment and HIV-1 vaccine design.", "Eighteen Cameroonian URFs from samples collected between the years 2000 and 2015 were studied using a newly developed near full genome sequencing (NFGS) protocol based on variable nested RT-PCRs with a versatile primer set. Near full genomes were characterized for recombination patterns and sequence signatures with possible impact on antiretroviral treatment or Env-directed immune responses. Third-generation sequencing (3GS) of near full or half genomes (HGs) gave insight into intra-patient URF diversity.", "The characterized URFs were composed of a broad variety of subtypes and recombinants including A, F, G, CRF01_AE, CRF02_AG and CRF22_01A1. Phylogenetic analysis unveiled dominant CRF02_AG and F2 recombination patterns. 3GS indicated a high intra-patient URF diversity with up to four distinct viral sub-populations present in plasma at the same time. URF pol genomic analysis revealed a number of accessory drug resistance mutations (DRMs) in the ART-na\u00efve participants. Genotypic env analysis suggests CCR5 usage in 14/18 samples and identified deviations at residues, critical for gp120/gp41 interphase and CD4 binding site broadly neutralizing antibodies in more than half of the studied URFs. V1V2 sites of immune pressure in the human RV144 vaccine study varied in more than a third of URFs.", "This study identified novel mosaic patterns in URFs in Cameroon. In line with the regional predominance of CRF_02AG and the increased prevalence of clade F2, prominent CRF_02AG and F2 background patterns were observed underlying the URFs. In the context of the novel mosaic genomes, the impact of the identified accessory DRMs and Env epitope variations on treatment and immune control remains elusive. The evolving diversity of HIV-1 URFs in Cameroon requires continuous monitoring to respond to the increasing challenges for diagnosis, antiretroviral treatment and prevention."], "CopyrightInformation": "\u00a9 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, USA."}, {"Identifier": [], "Affiliation": "Faculty of Medicine and Biomedical Sciences, University of Yaound\u00e9 1, Yaound\u00e9, Cameroon."}], "LastName": "Banin", "ForeName": "Andrew N", "Initials": "AN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, USA."}], "LastName": "Tuen", "ForeName": "Michael", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, USA."}, {"Identifier": [], "Affiliation": "Faculty of Science, Department of Biochemistry, University of Yaound\u00e9 1, Yaound\u00e9, Cameroon."}], "LastName": "Bimela", "ForeName": "Jude S", "Initials": "JS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Research for Emerging and Re-Emerging Diseases (CREMER), Institute of Medical Research and Study of Medicinal Plants, Yaound\u00e9, Cameroon."}], "LastName": "Tongo", "ForeName": "Marcel", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, USA."}], "LastName": "Zappile", "ForeName": "Paul", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Bioinformatics Laboratories (ABL) and Genome Technology Center (GTC), Division of Advanced Research Technologies (DART), New York University Langone Medical Center, New York, NY, USA."}], "LastName": "Khodadadi-Jamayran", "ForeName": "Alireza", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, USA."}, {"Identifier": [], "Affiliation": "Medical Diagnostic Center, Yaound\u00e9, Cameroon."}, {"Identifier": [], "Affiliation": "Chantal Biya International Reference Center for Research on HIV/AIDS Prevention and Management, Yaound\u00e9, Cameroon."}], "LastName": "Nanfack", "ForeName": "Aubin J", "Initials": "AJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Virus Research Unit, Department of Microbiology, University of Port Harcourt, Port Harcourt, Nigeria."}], "LastName": "Okonko", "ForeName": "Iheanyi O", "Initials": "IO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Diagnostic Center, Yaound\u00e9, Cameroon."}], "LastName": "Meli", "ForeName": "Josephine", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Manhattan Veterans Affairs Harbor Healthcare Systems, New York, NY, USA."}], "LastName": "Wang", "ForeName": "Xiaohong", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine and Biomedical Sciences, University of Yaound\u00e9 1, Yaound\u00e9, Cameroon."}], "LastName": "Mbanya", "ForeName": "Dora", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine and Biomedical Sciences, University of Yaound\u00e9 1, Yaound\u00e9, Cameroon."}], "LastName": "Ngogang", "ForeName": "Jeanne", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, USA."}], "LastName": "Gorny", "ForeName": "Miroslaw K", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, USA."}], "LastName": "Heguy", "ForeName": "Adriana", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine and Biomedical Sciences, University of Yaound\u00e9 1, Yaound\u00e9, Cameroon."}], "LastName": "Fokunang", "ForeName": "Charles", "Initials": "C"}, {"Identifier": ["0000-0001-9569-9237"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, New York University School of Medicine, New York, NY, USA."}, {"Identifier": [], "Affiliation": "Manhattan Veterans Affairs Harbor Healthcare Systems, New York, NY, USA."}], "LastName": "Duerr", "ForeName": "Ralf", "Initials": "R"}], "GrantList": [{"GrantID": "107", "Agency": "Welcome Trust", "Country": "International"}, {"GrantID": "752/Z/15/Z", "Agency": "Welcome Trust", "Country": "International"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "J Int AIDS Soc", "NlmUniqueID": "101478566", "ISSNLinking": "1758-2652"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-HIV Agents"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-HIV Agents"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Cameroon"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Genome, Viral"}, {"QualifierName": ["drug therapy", "epidemiology", "virology"], "DescriptorName": "HIV Infections"}, {"QualifierName": [], "DescriptorName": "HIV Seropositivity"}, {"QualifierName": ["genetics"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Longitudinal Studies"}, {"QualifierName": [], "DescriptorName": "Mutation"}, {"QualifierName": [], "DescriptorName": "Phylogeny"}, {"QualifierName": [], "DescriptorName": "Polymerase Chain Reaction"}, {"QualifierName": ["genetics"], "DescriptorName": "Reassortant Viruses"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hemelaar J, Elangovan R, Yun J, Dickson\u2010Tetteh L, Fleminger I, Kirtley S, et\u00a0al. Global and regional molecular epidemiology of HIV\u20101, 1990\u20102015: a systematic review, global survey, and trend analysis. Lancet Infect Dis. 2019;19(2):143\u201355.", "ArticleIdList": ["30509777"]}, {"Citation": "Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, et\u00a0al. Chimpanzee reservoirs of pandemic and nonpandemic HIV\u20101. Science. 2006;313(5786):523\u20136.", "ArticleIdList": ["PMC2442710", "16728595"]}, {"Citation": "Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1(1):a006841.", "ArticleIdList": ["PMC3234451", "22229120"]}, {"Citation": "\nMcNeil D Jr. Chimp to man to history: the path of AIDS. The New York Times. 2011 October 17, 2011.  [cited 2018 Nov 19]. Available from: https://www.nytimes.com/2011/10/18/health/18aids.html\n"}, {"Citation": "Tongo M, Martin DP, Zembe L, Mpoudi\u2010Ngole E, Williamson C, Burgers WA. Characterization of HIV\u20101 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV\u20101 group M epidemic. Virol J. 2013;10:29.", "ArticleIdList": ["PMC3560183", "23339631"]}, {"Citation": "Tebit DM, Arts EJ. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect Dis. 2011;11(1):45\u201356.", "ArticleIdList": ["21126914"]}, {"Citation": "Faria NR, Rambaut A, Suchard MA, Baele G, Bedford T, Ward MJ, et\u00a0al. HIV epidemiology. The early spread and epidemic ignition of HIV\u20101 in human populations. Science. 2014;346(6205):56\u201361.", "ArticleIdList": ["PMC4254776", "25278604"]}, {"Citation": "Peeters M, Jung M, Ayouba A. The origin and molecular epidemiology of HIV. Expert Rev Anti Infect Ther. 2013;11(9):885\u201396.", "ArticleIdList": ["24011334"]}, {"Citation": "Vergne L, Bourgeois A, Mpoudi\u2010Ngole E, Mougnutou R, Mbuagbaw J, Liegeois F, et\u00a0al. Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI\u2010inducing phenotype of the predominant CRF02_AG variant and disease stage. Virology. 2003;310(2):254\u201366.", "ArticleIdList": ["12781713"]}, {"Citation": "Brennan CA, Bodelle P, Coffey R, Devare SG, Golden A, Hackett J Jr, et\u00a0al. The prevalence of diverse HIV\u20101 strains was stable in Cameroonian blood donors from 1996 to 2004. J Acquir Immune Defic Syndr. 2008;49(4):432\u20139.", "ArticleIdList": ["18931623"]}, {"Citation": "Ragupathy V, Zhao J, Wood O, Tang S, Lee S, Nyambi P, et\u00a0al. Identification of new, emerging HIV\u20101 unique recombinant forms and drug resistant viruses circulating in Cameroon. Virol J. 2011;8:185.", "ArticleIdList": ["PMC3118203", "21513545"]}, {"Citation": "Courtney CR, Agyingi L, Fokou A, Christie S, Asaah B, Meli J, et\u00a0al. Monitoring HIV\u20101 group M subtypes in Yaounde, Cameroon reveals broad genetic diversity and a novel CRF02_AG/F2 infection. AIDS Res Hum Retroviruses. 2016;32(4):381\u20135.", "ArticleIdList": ["PMC4817561", "26681241"]}, {"Citation": "Nanfack AJ, Redd AD, Bimela JS, Ncham G, Achem E, Banin AN, et\u00a0al. Multimethod longitudinal HIV drug resistance analysis in antiretroviral\u2010therapy\u2010naive patients. J Clin Microbiol. 2017;55(9):2785\u2013800.", "ArticleIdList": ["PMC5648714", "28659324"]}, {"Citation": "Nkengasong JN, Janssens W, Heyndrickx L, Fransen K, Ndumbe PM, Motte J, et\u00a0al. Genotypic subtypes of HIV\u20101 in Cameroon. AIDS. 1994;8(10):1405\u201312.", "ArticleIdList": ["7818811"]}, {"Citation": "Fonjungo PN, Mpoudi EN, Torimiro JN, Alemnji GA, Eno LT, Lyonga EJ, et\u00a0al. Human immunodefiency virus type 1 group M protease in Cameroon: genetic diversity and protease inhibitor mutattional features. J Clin Microbiol. 2001;40:837\u201345.", "ArticleIdList": ["PMC120267", "11880402"]}, {"Citation": "Torimiro JN, D'Arrigo R, Takou D, Nanfack A, Pizzi D, Ngong I, et\u00a0al. Human immunodeficiency virus type 1 intersubtype recombinants predominate in the AIDS epidemic in Cameroon. New Microbiol. 2009;32(4):325\u201331.", "ArticleIdList": ["20128438"]}, {"Citation": "Agyingi L, Mayr LM, Kinge T, Orock GE, Ngai J, Asaah B, et\u00a0al. The evolution of HIV\u20101 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations. J Med Virol. 2014;86(3):385\u201393.", "ArticleIdList": ["PMC4011137", "24248638"]}, {"Citation": "Carr JK, Wolfe ND, Torimiro JN, Tamoufe U, Mpoudi\u2010Ngole E, Eyzaguirre L, et\u00a0al. HIV\u20101 recombinants with multiple parental strains in low\u2010prevalence, remote regions of Cameroon: evolutionary relics? Retrovirology. 2010;7:39.", "ArticleIdList": ["PMC2879232", "20426823"]}, {"Citation": "Hemelaar J, Gouws E, Ghys PD, Osmanov S; W\u2010UNfH, Characterisation . Global trends in molecular epidemiology of HIV\u20101 during 2000\u20102007. AIDS. 2011;25(5):679\u201389.", "ArticleIdList": ["PMC3755761", "21297424"]}, {"Citation": "Konings FA, Haman GR, Xue Y, Urbanski MM, Hertzmark K, Nanfack A, et\u00a0al. Genetic analysis of HIV\u20101 strains in rural eastern Cameroon indicates the evolution of second\u2010generation recombinants to circulating recombinant forms. J Acquir Immune Defic Syndr. 2006;42(3):331\u201341.", "ArticleIdList": ["16639350"]}, {"Citation": "Courtney CR, Mayr L, Nanfack AJ, Banin AN, Tuen M, Pan R, et\u00a0al. Contrasting antibody responses to intrasubtype superinfection with CRF02_AG. PLoS One. 2017;12(3):e0173705.", "ArticleIdList": ["PMC5348025", "28288209"]}, {"Citation": "\nHIV Circulating Recombinant Forms (CRFs)\n, HIV Sequence Database, Los Alamos National Laboratory, NM, USA [cited 2019 Apr 30]. Available from: https://www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html\n"}, {"Citation": "Tongo M, Dorfman JR, Abrahams MR, Mpoudi\u2010Ngole E, Burgers WA, Martin DP. Near full\u2010length HIV type 1M genomic sequences from Cameroon: evidence of early diverging under\u2010sampled lineages in the country. Evol Med Public Health. 2015;2015(1):254\u201365.", "ArticleIdList": ["PMC4600344", "26354000"]}, {"Citation": "Tongo M, Dorfman JR, Martin DP. High degree of HIV\u20101 group M (HIV\u20101M) genetic diversity within Circulating recombinant forms: insight into the early events of HIV\u20101M evolution. J Virol. 2015;90(5):2221\u20139.", "ArticleIdList": ["PMC4810712", "26656688"]}, {"Citation": "Rodgers MA, Wilkinson E, Vallari A, McArthur C, Sthreshley L, Brennan CA, et\u00a0al. Sensitive next\u2010generation sequencing method reveals deep genetic diversity of HIV\u20101 in the democratic republic of the Congo. J Virol. 2017;91(6):e01841\u201316.", "ArticleIdList": ["PMC5331799", "28077647"]}, {"Citation": "Fan J, Negroni M, Robertson DL. The distribution of HIV\u20101 recombination breakpoints. Infect Genet Evol. 2007;7(6):717\u201323.", "ArticleIdList": ["17851137"]}, {"Citation": "Smyth RP, Schlub TE, Grimm AJ, Waugh C, Ellenberg P, Chopra A, et\u00a0al. Identifying recombination hot spots in the HIV\u20101 genome. J Virol. 2014;88(5):2891\u2013902.", "ArticleIdList": ["PMC3958072", "24371048"]}, {"Citation": "Archer J, Pinney JW, Fan J, Simon\u2010Loriere E, Arts EJ, Negroni M, et\u00a0al. Identifying the important HIV\u20101 recombination breakpoints. PLoS Comput Biol. 2008;4(9):e1000178.", "ArticleIdList": ["PMC2522274", "18787691"]}, {"Citation": "Powell RL, Zhao J, Konings FA, Tang S, Ewane L, Burda S, et\u00a0al. Circulating recombinant form (CRF) 37_cpx: an old strain in Cameroon composed of diverse, genetically distant lineages of subtypes A and G. AIDS Res Hum Retroviruses. 2007;23(7):923\u201333.", "ArticleIdList": ["17678477"]}, {"Citation": "Powell RL, Zhao J, Konings FA, Tang S, Nanfack A, Burda S, et\u00a0al. Identification of a novel circulating recombinant form (CRF) 36_cpx in Cameroon that combines two CRFs (01_AE and 02_AG) with ancestral lineages of subtypes A and G. AIDS Res Hum Retroviruses. 2007;23(8):1008\u201319.", "ArticleIdList": ["17725418"]}, {"Citation": "Banin AN, Tuen M, Bimela JS, Tongo M, Zappile P, Khodadadi\u2010Jamayran A, et\u00a0al. Development of a versatile, near full genome amplification and sequencing approach for a broad variety of HIV\u20101 group M variants. Viruses. 2019;11(4):317.", "ArticleIdList": ["PMC6520859", "30939815"]}, {"Citation": "Powell R, Barengolts D, Mayr L, Nyambi P. The evolution of HIV\u20101 diversity in rural cameroon and its implications in vaccine design and trials. Viruses. 2010;2(2):639\u201354.", "ArticleIdList": ["PMC2975583", "21072143"]}, {"Citation": "Zhong P, Burda S, Urbanski M, Kenfack H, Tongo M, Heyndrickx L, et\u00a0al. HIV type 1 group M clades infecting subjects from rural villages in equatorial rain forests of Cameroon. J Acquir Immune Defic Syndr. 2002;31(5):495\u2013505.", "ArticleIdList": ["12473838"]}, {"Citation": "\nHIV Sequence Database\n, Los Alamos National Laboratory, NM, USA [cited 2019 Apr 30]. Available from: https://www.hiv.lanl.gov/content/sequence/HIV/mainpage.html\n"}, {"Citation": "Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731\u20139.", "ArticleIdList": ["PMC3203626", "21546353"]}, {"Citation": "Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post\u2010analysis of large phylogenies. Bioinformatics. 2014;30(9):1312\u20133.", "ArticleIdList": ["PMC3998144", "24451623"]}, {"Citation": "Miller M, Pfeiffer W, Schwartz T. Creating the CIPRES Science Gateway for inference of large phylogenetic trees. 2010 Gateway Computing Environments Workshop (GCE); New Orleans, LA: IEEE; 2010. p. 1\u20138."}, {"Citation": "Stamatakis A, Alachiotis N. Time and memory efficient likelihood\u2010based tree searches on phylogenomic alignments with missing data. Bioinformatics. 2010;26(12):i132\u20139.", "ArticleIdList": ["PMC2881390", "20529898"]}, {"Citation": "Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, et\u00a0al. Drug resistance mutations for surveillance of transmitted HIV\u20101 drug\u2010resistance: 2009 update. PLoS One. 2009;4(3):e4724.", "ArticleIdList": ["PMC2648874", "19266092"]}, {"Citation": "\nWHO\n. HIV drug resistance report 2017. Geneva: 2017.  [cited 2019 Apr 30]. Available from: https://apps.who.int/iris/bitstream/handle/10665/255896/9789241512831-eng.pdf\n"}, {"Citation": "Gunthard HF, Calvez V, Paredes R, Pillay D, Shafer RW, Wensing AM, et\u00a0al. Human immunodeficiency virus drug resistance: 2018 recommendations of the international antiviral society\u2010USA panel. Clin Infect Dis. 2019;68(2):177\u201387.", "ArticleIdList": ["PMC6321850", "30052811"]}, {"Citation": "Wensing AM, Calvez V, Gunthard HF, Johnson VA, Paredes R, Pillay D, et\u00a0al. 2017 update of the drug resistance mutations in HIV\u20101. Top Antivir Med. 2017;24(4):132\u20133.", "ArticleIdList": ["PMC5677049", "28208121"]}, {"Citation": "Soulie C, Fofana DB, Boukli N, Sayon S, Lambert\u2010Niclot S, Wirden M, et\u00a0al. Performance of genotypic algorithms for predicting tropism of HIV\u20101CRF02_AG subtype. J Clin Virol. 2016;76:51\u20134.", "ArticleIdList": ["26826578"]}, {"Citation": "Cashin K, Gray LR, Harvey KL, Perez\u2010Bercoff D, Lee GQ, Sterjovski J, et\u00a0al. Reliable genotypic tropism tests for the major HIV\u20101 subtypes. Sci Rep. 2015;5:8543.", "ArticleIdList": ["PMC4894445", "25712827"]}, {"Citation": "Rerks\u2010Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et\u00a0al. Vaccination with ALVAC and AIDSVAX to prevent HIV\u20101 infection in Thailand. N Engl J Med. 2009;361(23):2209\u201320.", "ArticleIdList": ["19843557"]}, {"Citation": "Rolland M, Edlefsen PT, Larsen BB, Tovanabutra S, Sanders\u2010Buell E, Hertz T, et\u00a0al. Increased HIV\u20101 vaccine efficacy against viruses with genetic signatures in Env V2. Nature. 2012;490(7420):417\u201320.", "ArticleIdList": ["PMC3551291", "22960785"]}, {"Citation": "deCamp A, Hraber P, Bailer RT, Seaman MS, Ochsenbauer C, Kappes J, et\u00a0al. Global panel of HIV\u20101 Env reference strains for standardized assessments of vaccine\u2010elicited neutralizing antibodies. J Virol. 2014;88(5):2489\u2013507.", "ArticleIdList": ["PMC3958090", "24352443"]}, {"Citation": "Falkowska E, Le KM, Ramos A, Doores KJ, Lee JH, Blattner C, et\u00a0al. Broadly neutralizing HIV antibodies define a glycan\u2010dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers. Immunity. 2014;40(5):657\u201368.", "ArticleIdList": ["PMC4070425", "24768347"]}, {"Citation": "Scheid JF, Mouquet H, Ueberheide B, Diskin R, Klein F, Oliveira TY, et\u00a0al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science. 2011;333(6049):1633\u20137.", "ArticleIdList": ["PMC3351836", "21764753"]}, {"Citation": "Ndembi N, Abraha A, Pilch H, Ichimura H, Mbanya D, Kaptue L, et\u00a0al. Molecular characterization of human immunodeficiency virus type 1 (HIV\u20101) and HIV\u20102 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. J Clin Microbiol. 2008;46(1):177\u201384.", "ArticleIdList": ["PMC2224252", "17855574"]}, {"Citation": "Zhao J, Tang S, Ragupathy V, Gaddam D, Wang X, Zhang P, et\u00a0al. CRF22_01A1 is involved in the emergence of new HIV\u20101 recombinants in Cameroon. J Acquir Immune Defic Syndr. 2012;60(4):344\u201350.", "ArticleIdList": ["PMC3392544", "22549382"]}, {"Citation": "Aghokeng AF, Vergne L, Mpoudi\u2010Ngole E, Mbangue M, Deoudje N, Mokondji E, et\u00a0al. Evaluation of transmitted HIV drug resistance among recently\u2010infected antenatal clinic attendees in four Central African countries. Antivir Ther. 2009;14(3):401\u201311.", "ArticleIdList": ["19474474"]}, {"Citation": "Burda ST, Viswanath R, Zhao J, Kinge T, Anyangwe C, Tinyami ET, et\u00a0al. HIV\u20101 reverse transcriptase drug\u2010resistance mutations in chronically infected individuals receiving or naive to HAART in Cameroon. J Med Virol. 2010;82(2):187\u201396.", "ArticleIdList": ["PMC2958705", "20029816"]}, {"Citation": "Ceccarelli L, Salpini R, Moudourou S, Cento V, Santoro MM, Fokam J, et\u00a0al. Characterization of drug resistance mutations in naive and ART\u2010treated patients infected with HIV\u20101 in Yaounde. Cameroon. J Med Virol. 2012;84(5):721\u20137.", "ArticleIdList": ["22431019"]}, {"Citation": "Koizumi Y, Ndembi N, Miyashita M, Lwembe R, Kageyama S, Mbanya D, et\u00a0al. Emergence of antiretroviral therapy resistance\u2010associated primary mutations among drug\u2010naive HIV\u20101\u2010infected individuals in rural western Cameroon. J Acquir Immune Defic Syndr. 2006;43(1):15\u201322.", "ArticleIdList": ["16885781"]}, {"Citation": "Ndongmo CB, Pieniazek D, Holberg\u2010Petersen M, Holm\u2010Hansen C, Zekeng L, Jeansson SL, et\u00a0al. HIV genetic diversity in Cameroon: possible public health importance. AIDS Res Hum Retroviruses. 2006;22(8):812\u20136.", "ArticleIdList": ["16910839"]}, {"Citation": "Ye C, Hill CM, Wu S, Ruan J, Ma ZS. DBG2OLC: efficient assembly of large genomes using long erroneous reads of the third generation sequencing technologies. Scie Rep. 2016;6:31900.", "ArticleIdList": ["PMC5004134", "27573208"]}, {"Citation": "Ekblom R, Wolf JB. A field guide to whole\u2010genome sequencing, assembly and annotation. Evol Appl. 2014;7(9):1026\u201342.", "ArticleIdList": ["PMC4231593", "25553065"]}, {"Citation": "Redd AD, Quinn TC, Tobian AA. Frequency and implications of HIV superinfection. Lancet Infect Dis. 2013;13(7):622\u20138.", "ArticleIdList": ["PMC3752600", "23726798"]}, {"Citation": "Aralaguppe SG, Siddik AB, Manickam A, Ambikan AT, Kumar MM, Fernandes SJ, et\u00a0al. Multiplexed next\u2010generation sequencing and de novo assembly to obtain near full\u2010length HIV\u20101 genome from plasma virus. J Virol Methods. 2016;236:98\u2013104.", "ArticleIdList": ["27448822"]}, {"Citation": "Jordan MR, Kearney M, Palmer S, Shao W, Maldarelli F, Coakley EP, et\u00a0al. Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV\u20101 populations. J Virol Methods. 2010;168(1\u20132):114\u201320.", "ArticleIdList": ["PMC3949620", "20451557"]}, {"Citation": "Tongo M, de Oliveira T, Martin DP. Patterns of genomic site inheritance in HIV\u20101M inter\u2010subtype recombinants delineate the most likely genomic sites of subtype\u2010specific adaptation. Virus Evol. 2018;4(1):vey015.", "ArticleIdList": ["PMC6007327", "29942655"]}, {"Citation": "Megens S, Laethem KV. HIV\u20101 genetic variation and drug resistance development. Expert Rev Anti Infect Ther. 2013;11(11):1159\u201378.", "ArticleIdList": ["24151833"]}, {"Citation": "Palumbo PJ, Wilson EA, Piwowar\u2010Manning E, McCauley M, Gamble T, Kumwenda N, et\u00a0al. Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052. PLoS One. 2017;12(5):e0177281.", "ArticleIdList": ["PMC5421787", "28481902"]}, {"Citation": "Apetrei C, Descamps D, Collin G, Loussert\u2010Ajaka I, Damond F, Duca M, et\u00a0al. Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. J Virol. 1998;72(5):3534\u20138.", "ArticleIdList": ["PMC109572", "9557632"]}, {"Citation": "Poveda E, de Mendoza C, Parkin N, Choe S, Garcia\u2010Gasco P, Corral A, et\u00a0al. Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV\u20101 subtypes. AIDS. 2008;22(5):611\u20136.", "ArticleIdList": ["18317002"]}, {"Citation": "Joos B, Trkola A, Fischer M, Kuster H, Rusert P, Leemann C, et\u00a0al. Low human immunodeficiency virus envelope diversity correlates with low in\u00a0vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions. J Virol. 2005;79(14):9026\u201337.", "ArticleIdList": ["PMC1168724", "15994796"]}, {"Citation": "Mani I, Gilbert P, Sankale JL, Eisen G, Mboup S, Kanki PJ. Intrapatient diversity and its correlation with viral setpoint in human immunodeficiency virus type 1 CRF02_A/G\u2010IbNG infection. J Virol. 2002;76(21):10745\u201355.", "ArticleIdList": ["PMC136616", "12368317"]}, {"Citation": "Sagar M, Lavreys L, Baeten JM, Richardson BA, Mandaliya K, Chohan BH, et\u00a0al. Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression. J Virol. 2003;77(23):12921\u20136.", "ArticleIdList": ["PMC262567", "14610215"]}, {"Citation": "Butler IF, Pandrea I, Marx PA, Apetrei C. HIV genetic diversity: biological and public health consequences. Curr HIV Res. 2007;5(1):23\u201345.", "ArticleIdList": ["17266555"]}, {"Citation": "Hemelaar J. Implications of HIV diversity for the HIV\u20101 pandemic. J Infect. 2013;66(5):391\u2013400.", "ArticleIdList": ["23103289"]}, {"Citation": "Brown BL, Watson M, Minot SS, Rivera MC, Franklin RB. MinION nanopore sequencing of environmental metagenomes: a synthetic approach. Gigascience. 2017;6(3):1\u201310.", "ArticleIdList": ["PMC5467020", "28327976"]}, {"Citation": "Jain M, Koren S, Miga KH, Quick J, Rand AC, Sasani TA, et\u00a0al. Nanopore sequencing and assembly of a human genome with ultra\u2010long reads. Nat Biotechnol. 2018;36(4):338\u201345.", "ArticleIdList": ["PMC5889714", "29431738"]}]}], "History": [{"Year": "2018", "Month": "12", "Day": "19"}, {"Year": "2019", "Month": "7", "Day": "4"}, {"Year": "2019", "Month": "7", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "28"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31353798", "PMC6661401", "10.1002/jia2.25362"]}}]}